Erasca ERAS
NASDAQ ERAS
$14.74 +0.16 (+1.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

Erasca (ERAS) Return on Equity [ROE] (2021 - 2026)

Updated

Erasca (ERAS) reported Return on Equity [ROE] of -80.14% for Q2 2026, down 42.12 percentage points from -38.02% a year earlier but up 1.45 percentage points from the prior quarter.

Analysis

Erasca (ERAS) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Erasca posted Return on Equity [ROE] of -37.64%, up 10.88 percentage points from FY2024.

  • Return on Equity [ROE] has a four-year change of +35.27 percentage points (FY2021 to FY2025).
  • By year, Return on Equity [ROE] came in at -48.52% in FY2024 (-9.67 pp), -38.85% in FY2023 (+18.14 pp), -56.99% in FY2022 (+15.92 pp) and -72.92% in FY2021.
  • Five-year quarterly Return on Equity [ROE] spans a low of -96.58% in Q3 2021 and a high of -26.58% in Q4 2021.
  • Year over year, Return on Equity [ROE] has now declined in each of the last four quarters, with an average year-over-year change of -4.45 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q3 2022 (a gain of 59.65 percentage points); the low point was Q2 2026 (a drop of 42.12 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -81.59% (Q1 2026), -41.87% (Q4 2025) and -40.00% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Erasca 4.61 Bn 4.61 Bn - -80.14%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -80.14%
Mar 31, 2026 -81.59%
Dec 31, 2025 -41.87%
Sep 30, 2025 -40.00%
Jun 30, 2025 -38.02%
Mar 31, 2025 -42.86%
Dec 31, 2024 -41.12%
Sep 30, 2024 -39.45%
Jun 30, 2024 -47.37%
Mar 31, 2024 -47.38%
Dec 31, 2023 -43.17%
Sep 30, 2023 -70.04%
Jun 30, 2023 -66.22%
Mar 31, 2023 -62.12%
Dec 31, 2022 -63.68%
Sep 30, 2022 -36.93%
Jun 30, 2022 -36.48%
Mar 31, 2022 -32.18%
Dec 31, 2021 -26.58%
Sep 30, 2021 -96.58%
API Access

Erasca Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ERAS&period=max&api_key=YOUR_API_KEY